Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pneumonia, Secretion discharge
Clinical narrative: COVID-19, Pneumonia, Mucus discharge, Nauseous, COVID-19 recurrent; pneomonia; Mucus discharge; COVID-19 recurrent; nausea; headache; body ache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of COVID-19 (COVID-19, Pneumonia, Mucus discharge, Nauseous, COVID-19 recurrent) and PNEUMONIA (pneomonia) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product IBRUTINIB (IMBRUVICA) capsule for Chronic lymphocytic leukemia.    No Medical History information was reported.   On 10-Apr-2019, the patient started IBRUTINIB (IMBRUVICA) (Oral) 140 mg twice a day. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced COVID-19 (COVID-19, Pneumonia, Mucus discharge, Nauseous, COVID-19 recurrent) (seriousness criterion hospitalization) and PNEUMONIA (pneomonia) (seriousness criteria hospitalization and medically significant). On an unknown date, the patient experienced SECRETION DISCHARGE (Mucus discharge), COVID-19 (COVID-19 recurrent), NAUSEA (nausea), HEADACHE (headache) and MYALGIA (body ache). The patient was hospitalized from 08-Jan-2021 to 12-Jan-2021 due to COVID-19. On 13-Jan-2021, COVID-19 (COVID-19, Pneumonia, Mucus discharge, Nauseous, COVID-19 recurrent) and PNEUMONIA (pneomonia) was resolving. At the time of the report, SECRETION DISCHARGE (Mucus discharge), COVID-19 (COVID-19 recurrent), NAUSEA (nausea), HEADACHE (headache) and MYALGIA (body ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: normal (normal) Had CT scan 2 weeks ago, which is clean and clear.. On an unknown date, Coronavirus test: positive (Positive) Covid-19 test positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medication information provided.  Patient had COVID in January, was hospitalized for 5 days, lost his sense of smell and taste, which hasn't fully recovered, but is feeling better and still had fatigue. Patient had pneumonia with shortness of breath which is dissipating. Patient had taken Moderna covid vaccines, stated reactions with first time felt like he had covid again for a couple of days, and the second one gave him headaches and body aches for a day. Patient stated  his doctor says he did build up immunity from vaccine, noted from test. The medication was held when had covid for a week or two.   No relevant treatment medication information provided.  Based on the mechanism of action of mRNA-1273, the event (Covid-19) is assessed as unlikely related to mRNA-1273. Very limited information regarding these event (pneumonia and other events) has been provided at this time. However, it is not clear if COVID-19 and pneumonia occurred prior to 1st dose of mRNA-1273.; Sender's Comments: Based on the mechanism of action of mRNA-1273, the event (Covid-19) is assessed as unlikely related to mRNA-1273. Very limited information regarding these event (pneumonia and other events) has been provided at this time. However, it is not clear if COVID-19 and pneumonia occurred prior to 1st dose of mRNA-1273.